Silk Road Medical, Inc

Symbol: SILK

NASDAQ

18.97

USD

Market price today

  • -15.0008

    P/E Ratio

  • 0.1739

    PEG Ratio

  • 743.14M

    MRK Cap

  • 0.00%

    DIV Yield

Silk Road Medical, Inc (SILK) Financial Statements

On the chart you can see the default numbers in dynamics for Silk Road Medical, Inc (SILK). Companys revenue shows the average of NaN M which is NaN % gowth. The average gross profit for the whole period is NaN M which is NaN %. The average gross profit ratio is NaN %. The net income growth for the company last year performance is NaN % which equals NaN % % on average for the whole company history.,

Balance Sheet

Diving into the fiscal trajectory of Silk Road Medical, Inc, we observe an average asset growth. This rate, interestingly, stands at , reflecting both the company's highs and lows. When compared quarter-over-quarter, this figure adjusts to . A look back at the past year reveals a total asset change of NaN. Shareholder value, as depicted by the total shareholder equity, is valued at NaN in the reporting currency. The year over year change in this aspect is NaN%.

common:word.in-mln

USD
Growth
TTM2023202220212020201920182017

balance-sheet.row.cash-and-short-term-investments

0181.5213.7110.2
147.5
90.7
25
33.3

balance-sheet.row.short-term-investments

0161.3158.30
78
51.5
0
0

balance-sheet.row.net-receivables

023.61811.8
9.1
8.6
4.5
5.2

balance-sheet.row.inventory

029.919.317.9
10
10.3
5.7
3.2

balance-sheet.row.other-current-assets

05.93.93.4
6.8
2.9
1.4
0.3

balance-sheet.row.total-current-assets

0240.8254.9143.3
173.3
112.5
36.7
42.1

balance-sheet.row.property-plant-equipment-net

014.69.47.7
2.8
2.7
2.9
0.5

balance-sheet.row.goodwill

0000
0
0
0
0

balance-sheet.row.intangible-assets

000.10.1
0
0
0
0

balance-sheet.row.goodwill-and-intangible-assets

000.10.1
0
0
0
0

balance-sheet.row.long-term-investments

09.50.20.2
0.3
18.2
0
0

balance-sheet.row.tax-assets

00-0.2-0.3
0
0
0
0

balance-sheet.row.other-non-current-assets

00.45.35.6
2.8
4
1.3
0.5

balance-sheet.row.total-non-current-assets

024.514.813.3
6
24.9
4.2
1

balance-sheet.row.other-assets

0000
0
0
0
0

balance-sheet.row.total-assets

0265.3269.7156.6
179.3
137.4
40.9
43.1

balance-sheet.row.account-payables

05.72.52.4
2.6
1.9
1.3
1.5

balance-sheet.row.short-term-debt

01.71.83.9
0.8
0.8
0
0

balance-sheet.row.tax-payables

0000
0
0
0
0

balance-sheet.row.long-term-debt-total

075.674.644.8
48.5
44.9
44.2
27.6

Deferred Revenue Non Current

0000
0
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

0---
-
-
-
-

balance-sheet.row.other-current-liab

022.819.919.6
15.9
14
7.6
3.1

balance-sheet.row.total-non-current-liabilities

083.981.351.3
52.3
48.6
45.3
137

balance-sheet.row.other-liabilities

0000
0
0
0
0

balance-sheet.row.capital-lease-obligations

07.31.81.3
0.8
3.7
0
0

balance-sheet.row.total-liab

0114.2105.877.4
71.8
65.5
54.1
141.7

balance-sheet.row.preferred-stock

0000
0
0
0
0

balance-sheet.row.common-stock

0000
0
0
0
0

balance-sheet.row.retained-earnings

0-399.5-343.7-288.7
-238.9
-191.5
-139.1
-101.6

balance-sheet.row.accumulated-other-comprehensive-income-loss

00.1-0.20
0
0
-0.9
-1.3

balance-sheet.row.other-total-stockholders-equity

0550.5507.7367.9
346.3
263.4
126.8
4.3

balance-sheet.row.total-stockholders-equity

0151.2163.979.2
107.5
71.9
-13.2
-98.6

balance-sheet.row.total-liabilities-and-stockholders-equity

0265.3269.7156.6
179.3
137.4
40.9
43.1

balance-sheet.row.minority-interest

0000
0
0
0
0

balance-sheet.row.total-equity

0151.2163.979.2
107.5
71.9
-13.2
-

balance-sheet.row.total-liabilities-and-total-equity

0---
-
-
-
-

Total Investments

0170.7158.30.2
78
69.7
0
0

balance-sheet.row.total-debt

084.676.448.7
48.5
44.9
44.2
27.6

balance-sheet.row.net-debt

064.421.1-61.5
-20.9
5.7
19.2
-5.7

Cash Flow Statement

The financial landscape of Silk Road Medical, Inc has seen a noteworthy change in free cash flow over the last period, exhibiting a shift of NaN. The company recently extended its share capital by issuing NaN, marking a difference of NaN compared to the previous year. The company's investing activities resulted in net cash usage, amounting to NaN in the reporting currency. This is a shift of NaN from the previous year. In the same period, the company recorded NaN, NaN, and NaN, which are significant to understanding the company's investment and repayment strategies. The company's financing activities led to a net cash usage of NaN, with a year over year difference of NaN. Furthermore, the company allocated NaN for dividend payouts to its shareholders. At the same time, it engaged in other financial maneuvers, referred to as NaN, which also significantly impacted its cash flow during this period. These components, taken together, paint a comprehensive picture of the company's financial status and strategic approach towards cash flow management.

common:word.in-mln

USD
Growth
TTM2023202220212020201920182017

cash-flows.row.net-income

0-55.7-55-49.8
-47.4
-52.4
-37.6
-19.4

cash-flows.row.depreciation-and-amortization

03.83.21.9
1.4
1.3
0.5
0.1

cash-flows.row.deferred-income-tax

0-59.800.7
-2.3
21.2
13.9
-2.5

cash-flows.row.stock-based-compensation

038.92514.6
7.2
3
0.9
0.5

cash-flows.row.change-in-working-capital

0-13.9-6-6.5
-1.4
-3
-1
-5.9

cash-flows.row.account-receivables

0-5.6-6.2-2.8
-0.4
-2.2
-1
-4.8

cash-flows.row.inventory

0-10.8-1.4-5.6
-2.2
-4.7
-2.6
-2.4

cash-flows.row.account-payables

03.11-1.2
0.6
0.6
-0.3
0.7

cash-flows.row.other-working-capital

0-0.60.63
0.6
3.3
2.8
0.6

cash-flows.row.other-non-cash-items

054.80.30.2
0.3
0.4
1.6
1.8

cash-flows.row.net-cash-provided-by-operating-activities

0000
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

0-1.5-5-4.8
-0.8
-0.5
-2.3
-0.4

cash-flows.row.acquisitions-net

00157.10
8.6
0
0
0

cash-flows.row.purchases-of-investments

0-175-168.20
-79.9
-69.4
0
0

cash-flows.row.sales-maturities-of-investments

0169.311.177.4
71.4
0
0
0

cash-flows.row.other-investing-activites

00-157.10
-8.6
0
0
0

cash-flows.row.net-cash-used-for-investing-activites

0-7.2-162.172.6
-9.4
-70
-2.3
-0.4

cash-flows.row.debt-repayment

00-490
-40
0
0
0

cash-flows.row.common-stock-issued

03.9114.86.9
75.7
111.9
0.7
0.3

cash-flows.row.common-stock-repurchased

0000
0
0
0
0

cash-flows.row.dividends-paid

0000
0
0
0
0

cash-flows.row.other-financing-activites

0073.90
46
1.8
14.8
46.8

cash-flows.row.net-cash-used-provided-by-financing-activities

03.9139.77
81.7
113.8
15.4
47.2

cash-flows.row.effect-of-forex-changes-on-cash

00.200
0
0
0
0

cash-flows.row.net-change-in-cash

0-35.1-5540.7
30.3
14.2
-8.5
21.5

cash-flows.row.cash-at-end-of-period

020.255.5110.5
69.8
39.5
25.3
33.8

cash-flows.row.cash-at-beginning-of-period

055.4110.569.8
39.5
25.3
33.8
12.4

cash-flows.row.operating-cash-flow

0-32-32.6-38.9
-42.1
-29.6
-21.7
-25.3

cash-flows.row.capital-expenditure

0-1.5-5-4.8
-0.8
-0.5
-2.3
-0.4

cash-flows.row.free-cash-flow

0-33.5-37.6-43.7
-42.9
-30.1
-24
-25.7

Income Statement Row

Silk Road Medical, Inc's revenue saw a change of NaN% compared with the previous period. The gross profit of SILK is reported to be NaN. The company's operating expenses are NaN, showing a change of NaN% from the last year. The expenses for depreciation and amortization are NaN, which is a NaN% change from the last accounting period. Operating expenses are reported to be NaN, which shows a NaN% year-over-year change. Selling and marketing expenses are NaN, which is a NaN% change compared to the previous year. The EBITDA based on the recent numbers is NaN, representing a NaN% year-over-year growth. The operating income is NaN, which shows a NaN% change when compared to the previous year. The change in the net income is NaN%. The net income for the last year was NaN.

common:word.in-mln

USD
Growth
TTM2023202220212020201920182017

income-statement-row.row.total-revenue

0177.1138.6101.5
75.2
63.4
34.6
14.3

income-statement-row.row.cost-of-revenue

05037.925.4
21.3
15.9
10.9
5.1

income-statement-row.row.gross-profit

0127.1100.876
53.9
47.4
23.7
9.1

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0

income-statement-row.row.research-development

0---
-
-
-
-

income-statement-row.row.selling-general-administrative

0---
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-

income-statement-row.row.other-expenses

00.4-0.20
-0.1
-21.1
-12.1
2.9

income-statement-row.row.operating-expenses

0186.4152.8123.5
96.8
75.5
45.1
27.5

income-statement-row.row.cost-and-expenses

0236.4190.6148.9
118.1
91.4
56
32.6

income-statement-row.row.interest-income

0102.50.2
1.1
1.7
0.2
0

income-statement-row.row.interest-expense

06.95.12.5
4.4
5
4.4
3.9

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-

income-statement-row.row.total-other-income-expensenet

03.5-3-2.3
-4.5
-24.4
-12.1
2.9

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-

income-statement-row.row.other-operating-expenses

00.4-0.20
-0.1
-21.1
-12.1
2.9

income-statement-row.row.total-operating-expenses

03.5-3-2.3
-4.5
-24.4
-12.1
2.9

income-statement-row.row.interest-expense

06.95.12.5
4.4
5
4.4
3.9

income-statement-row.row.depreciation-and-amortization

03.82.30.2
1.1
1.7
0.5
0.1

income-statement-row.row.ebitda-caps

0---
-
-
-
-

income-statement-row.row.operating-income

0-59.3-52-47.5
-42.9
-28.1
-21.4
-18.4

income-statement-row.row.income-before-tax

0-55.7-55-49.8
-47.4
-52.4
-37.6
-19.4

income-statement-row.row.income-tax-expense

0030.6
3
3.7
-11.9
6.9

income-statement-row.row.net-income

0-55.7-58-50.4
-50.4
-56.1
-37.6
-19.4

Frequently Asked Question

What is Silk Road Medical, Inc (SILK) total assets?

Silk Road Medical, Inc (SILK) total assets is 265309000.000.

What is enterprise annual revenue?

The annual revenue is N/A.

What is firm profit margin?

Firm profit margin is 0.733.

What is company free cash flow?

The free cash flow is -0.937.

What is enterprise net profit margin?

The net profit margin is -0.288.

What is firm total revenue?

The total revenue is -0.309.

What is Silk Road Medical, Inc (SILK) net profit (net income)?

The net profit (net income) is -55743000.000.

What is firm total debt?

The total debt is 84633000.000.

What is operating expences number?

The operating expences are 186357000.000.

What is company cash figure?

Enretprise cash is 0.000.